New combo therapy targets abdominal cancer spread in early trial
NCT ID NCT07453875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new treatment plan for people with stomach or colorectal cancer that has spread to the lining of the abdomen. The approach combines low-dose radiation to the whole abdomen with chemotherapy and an immunotherapy drug. The main goal is to check if the treatment is safe and tolerable. About 9 to 18 participants will take part at one hospital in China.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LDRT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Army Medical Center
Chongqing, Chongqing Municipality, 400042, China
-
Daping Hospital, Army Medical University
Chongqing, Chongqing Municipality, 400042, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.